[Elsevier] CO50 Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE) |
|
This post will be closed automatically in 2026-06-23 16:56
Reward10points
|
| |
10
A systematic study of novel CuTeSeA (A = Br, I) quaternary chalcohalides: For multifunctional energy applications
10
A holistic safety assessment for cargo holds and decks fire & explosion risks under fuzzy Bayesian network approach
10
Safety analysis of fire and explosion (F&E) accidents risk in bulk carrier ships under fuzzy fault tree approach
10
Vortioxetine improved negative and cognitive symptoms of schizophrenia in subchronic MK-801 model in rats
10
Antibacterial electrospun nanofibers for wound dressing applications
